Danas se najee koriste dve glavne generacije ovih lekova: GLP-1 agonisti (klasini pristup) dual agonisti (nova generacija) 1
Eliminating obesity in a vast subset of patients indicates a major sea change in healthcare and, like the introduction of statins, threatens a myriad of medical device categories from diabetes management devices to CPAP machines used for obstructive sleep apnea, and bariatric surgery, cardiovascular and orthopedic procedures
This helps us determine not just whether MOTS-C is appropriate, but how it should be delivered and at what dose to provide the most complete metabolic support
Dionyssopoulou E, Vassiliadis S, Evangeliou A, Koumantakis EE, Athanassakis I
GLP-1 agonists are typically initiated at low doses and gradually increased according to manufacturer guidelines, which helps minimise gastrointestinal side effects and may moderate the pace of weight reduction
Contact us today to schedule a consultation and start your transformation journey with us.